Your browser doesn't support javascript.
loading
Oxamniquine derivatives overcome Praziquantel treatment limitations for Schistosomiasis.
Alwan, Sevan N; Taylor, Alexander B; Rhodes, Jayce; Tidwell, Michael; McHardy, Stanton F; LoVerde, Philip T.
Afiliação
  • Alwan SN; Departments of Biochemistry and Structural Biology, University of Texas Health at San Antonio; San Antonio, Texas, Unites States of America.
  • Taylor AB; Biology Core Facilities, University of Texas Health at San Antonio; San Antonio, Texas, Unites States of America.
  • Rhodes J; Center for Innovative Drug Discovery, Department of Chemistry, University of Texas at San Antonio; San Antonio, Texas, Unites States of America.
  • Tidwell M; Center for Innovative Drug Discovery, Department of Chemistry, University of Texas at San Antonio; San Antonio, Texas, Unites States of America.
  • McHardy SF; Center for Innovative Drug Discovery, Department of Chemistry, University of Texas at San Antonio; San Antonio, Texas, Unites States of America.
  • LoVerde PT; Departments of Biochemistry and Structural Biology, University of Texas Health at San Antonio; San Antonio, Texas, Unites States of America.
PLoS Pathog ; 19(7): e1011018, 2023 07.
Article em En | MEDLINE | ID: mdl-37428793
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Esquistossomose / Esquistossomose mansoni / Anti-Helmínticos Limite: Animals / Humans Idioma: En Revista: PLoS Pathog Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Esquistossomose / Esquistossomose mansoni / Anti-Helmínticos Limite: Animals / Humans Idioma: En Revista: PLoS Pathog Ano de publicação: 2023 Tipo de documento: Article